CLRPF
Price
$2.85
Change
-$0.00 (-0.00%)
Updated
Jul 29 closing price
Capitalization
920.08M
MLTX
Price
$50.45
Change
-$1.90 (-3.63%)
Updated
Jul 30, 04:59 PM (EDT)
Capitalization
3.32B
8 days until earnings call
Interact to see
Advertisement

CLRPF vs MLTX

Header iconCLRPF vs MLTX Comparison
Open Charts CLRPF vs MLTXBanner chart's image
Clarity Pharmaceuticals
Price$2.85
Change-$0.00 (-0.00%)
Volume$7.7K
Capitalization920.08M
MoonLake Immunotherapeutics
Price$50.45
Change-$1.90 (-3.63%)
Volume$9.54K
Capitalization3.32B
CLRPF vs MLTX Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. MLTX commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Buy and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (CLRPF: $2.85 vs. MLTX: $52.35)
Brand notoriety: CLRPF and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 105% vs. MLTX: 65%
Market capitalization -- CLRPF: $920.08M vs. MLTX: $3.32B
CLRPF [@Biotechnology] is valued at $920.08M. MLTX’s [@Biotechnology] market capitalization is $3.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLRPF and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 6 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • CLRPF’s TA Score: 6 bullish, 3 bearish.
  • MLTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLRPF is a better buy in the short-term than MLTX.

Price Growth

CLRPF (@Biotechnology) experienced а +5.75% price change this week, while MLTX (@Biotechnology) price change was -2.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.59%. For the same industry, the average monthly price growth was +14.57%, and the average quarterly price growth was +40.08%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.33B) has a higher market cap than CLRPF($920M). CLRPF YTD gains are higher at: 5.360 vs. MLTX (-3.324). CLRPF has higher annual earnings (EBITDA): -66.98M vs. MLTX (-168.14M).
CLRPFMLTXCLRPF / MLTX
Capitalization920M3.33B28%
EBITDA-66.98M-168.14M40%
Gain YTD5.360-3.324-161%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A480M-
Total DebtN/A75.6M-
TECHNICAL ANALYSIS
Technical Analysis
CLRPFMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYDX13.490.22
+1.66%
American Century Global Real Estate R6
VICEX24.070.04
+0.17%
USA Mutuals Vice Investor
PJGZX23.020.02
+0.09%
PGIM Jennison Focused Value Z
OTCGX22.98-0.13
-0.56%
MFS Mid Cap Growth R1
IEOHX17.66-0.13
-0.73%
Voya Large Cap Growth Port I

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and ENLV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and ENLV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
N/A
ENLV - CLRPF
22%
Poorly correlated
+12.70%
JBPHF - CLRPF
14%
Poorly correlated
N/A
MLTX - CLRPF
11%
Poorly correlated
-3.89%
TELIF - CLRPF
10%
Poorly correlated
-8.36%
ACUT - CLRPF
9%
Poorly correlated
+3.42%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XNCR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-3.89%
XNCR - MLTX
46%
Loosely correlated
-2.33%
IDYA - MLTX
45%
Loosely correlated
-0.72%
XENE - MLTX
45%
Loosely correlated
-0.32%
CLDX - MLTX
44%
Loosely correlated
-0.27%
CRNX - MLTX
43%
Loosely correlated
-3.40%
More